MOL MED REP - Molecular medicine reports

Publications

  1. 2016
  2. Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer

    Lebok, P., Huber, J., Burandt, E-C., Lebeau, A., Marx, A. H., Terracciano, L., Heilenkötter, U., Jänicke, F., Müller, V., Paluchowski, P., Geist, S., Wilke, C., Simon, R., Sauter, G. & Quaas, A., 08.2016, In: MOL MED REP. 14, 2, p. 1443-50 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2008
  4. Rechallenge with temozolomide with different scheduling is effective in recurrent malignant gliomas.

    Strik, H. M., Buhk, J. H., Wrede, A., Hoffmann, A. L., Bock, H. C., Christmann, M. & Kaina, B., 2008, In: MOL MED REP. 1, 6, p. 863-867 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review